Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · IEX Real-Time Price · USD
0.293
-0.028 (-8.63%)
Jul 22, 2024, 10:19 AM EDT - Market open
Mustang Bio Employees
Mustang Bio had 80 employees as of December 31, 2023. The number of employees decreased by 33 or -29.20% compared to the previous year.
Employees
80
Change (1Y)
-33
Growth (1Y)
-29.20%
Revenue / Employee
n/a
Profits / Employee
-$501,250
Market Cap
9.98M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Senti Biosciences | 48 |
Calidi Biotherapeutics | 41 |
Vaccinex | 40 |
Dominari Holdings | 28 |
Traws Pharma | 18 |
Moleculin Biotech | 18 |
BioRestorative Therapies | 11 |
Inhibikase Therapeutics | 9 |
MBIO News
- 24 days ago - Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB) - GlobeNewsWire
- 4 weeks ago - Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 4 weeks ago - Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 4 weeks ago - Why are Mustang Bio shares (MBIO) up almost 500%? - Invezz
- 5 weeks ago - Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? - Benzinga
- 5 weeks ago - Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy - GlobeNewsWire
- 2 months ago - Mustang Bio Announces Closing of $4 Million Public Offering - GlobeNewsWire
- 2 months ago - Mustang Bio Announces Pricing of $4 Million Public Offering - GlobeNewsWire